Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years

Jahr

Publikationsjahr
2020

Autoren

Autorenliste der Publikation
Horáková D, Boster A, Bertolotto A, Freedman MS, Firmino I, Cavalier SJ, Jacobs AK, Thangavelu K, Daizadeh N, Poole EM, Baker DP, Margolin DH, Ziemssen T; CARE-MS I, CARE-MS II, and CAMMS03409 Investigators.

Verlag

Publisher-Information
Mult Scler J Exp Transl Clin. 2020 Dec 18;6(4):2055217320972137.

Link

Zur Publikation (externer Server)

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung